Edwards Lifesciences Corp Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Edwards Lifesciences Corp quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q3 2024.
  • Edwards Lifesciences Corp Other Assets, Noncurrent for the quarter ending September 30, 2024 was $684M, a 52.8% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $684M +$236M +52.8% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $790M +$378M +91.7% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $768M +$474M +161% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $463M +$164M +54.9% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $447M +$131M +41.4% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $412M +$177M +75.6% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $294M +$164M +127% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $299M +$188M +170% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $317M +$183M +137% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $235M +$129M +123% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $129M +$3.9M +3.11% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $111M -$8.8M -7.36% Dec 31, 2021 10-K 2023-02-13
Q3 2021 $134M -$4.3M -3.12% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $105M -$48.5M -31.5% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $126M -$19.8M -13.6% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $120M +$17.8M +17.5% Dec 31, 2020 10-K 2022-02-14
Q3 2020 $138M +$37.8M +37.7% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 $154M +$73.5M +91.5% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $145M +$69.8M +92.5% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $102M +$68.2M +203% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $100M +$65M +185% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $80.3M +$45.5M +131% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $75.5M +$17.7M +30.6% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $33.6M -$75.3M -69.1% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $35.2M -$77.2M -68.7% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $34.8M -$82M -70.2% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $57.8M -$70M -54.8% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $109M -$14.3M -11.6% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $112M -$12.4M -9.94% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $117M -$9.6M -7.6% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $128M -$3.3M -2.52% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $123M -$8.6M -6.53% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $125M +$69.9M +127% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $126M +$68.7M +119% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $131M +$77.7M +146% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $132M +$82.6M +168% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $54.9M +$17M +44.9% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $57.7M +$22M +61.6% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $53.4M +$18.2M +51.7% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $49.2M +$13.8M +39% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $37.9M +$6.9M +22.3% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $35.7M +$10.3M +40.6% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $35.2M +$9.6M +37.5% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $35.4M +$9.1M +34.6% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $31M +$5M +19.2% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $25.4M -$400K -1.55% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $25.6M -$200K -0.78% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $26.3M +$1.7M +6.91% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $26M +$1.4M +5.69% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $25.8M +$13.9M +117% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $25.8M +$13.8M +115% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $24.6M +$11.6M +89.2% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $24.6M +$12.5M +103% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $11.9M +$100K +0.85% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $12M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $13M Dec 31, 2010 10-K 2012-02-27
Q3 2010 $12.1M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $11.8M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.